Literature DB >> 7851494

Exendin-4 and exendin-(9-39)NH2: agonist and antagonist, respectively, at the rat parietal cell receptor for glucagon-like peptide-1-(7-36)NH2.

W Schepp1, J Schmidtler, T Riedel, K Dehne, V Schusdziarra, J J Holst, J Eng, J P Raufman, M Classen.   

Abstract

Exendin-4 is a novel peptide from Heloderma suspectum venom which is 53% homologous with glucagon-like peptide-1 GLP-1-(7-36)NH2, a stimulant of cAMP-dependent H+ production in rat parietal cells. It was the aim of the present study to determine whether this effect of GLP-1-(7-36)NH2 is shared by exendin-4, and whether the responses to either peptide are blocked by exendin-(9-39)NH2, a competitive specific exendin receptor antagonist. In enriched rat parietal cells H+ production was measured indirectly by [14C]aminopyrine accumulation. cAMP production was determined by radioimmunoassay. [125I]GLP-1-(7-36)NH2 was prepared using chloramine T followed by high pressure liquid chromatography (HPLC) purification. Exendin-4 (10(-12) - 10(-8) M) stimulated [14C]aminopyrine accumulation in a concentration-dependent manner (EC50 = 7.6 x 10(-11) M). At the maximally effective concentration (10(-9) M) exendin-4 was as effective as GLP-1-(7-36)NH2 reaching 70-80% of the response to 10(-4) M histamine. Likewise, exendin-4 (10(-11) - 10(-7) M) stimulated parietal cell cAMP production up to 2.8-fold. Maximal stimulation by exendin-4 of [14C]aminopyrine accumulation was not affected by ranitidine (10(-4) M), but was concentration-dependently reduced by exendin-(9-39)NH2 (10(-11) - 10(-7) M). At the maximal concentration, exendin-(9-39)NH2 completely abolished the responses to 10(-9) M exendin-4 and to 10(-9) M GLP-1-(7-36)NH2 while not altering stimulation by 10(-4) M histamine. Binding of [125I]GLP-1-(7-36)NH2 to enriched parietal cells was displaced by exendin-4 (Ki = 4.6 x 10(-10) M) as well as by exendin-(9-39)NH2 (Ki = 4.0 x 10(-9) M).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7851494     DOI: 10.1016/0922-4106(94)90085-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

Review 1.  The structure and function of the glucagon-like peptide-1 receptor and its ligands.

Authors:  Dan Donnelly
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Design, synthesis and crystallization of a novel glucagon analog as a therapeutic agent.

Authors:  Pengyun Li; Tanya Rogers; David Smiley; Richard D DiMarchi; Faming Zhang
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-06-15

3.  A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice.

Authors:  Desu Chen; Jiayu Liao; Na Li; Caihong Zhou; Qing Liu; Guangxing Wang; Rui Zhang; Song Zhang; Lilin Lin; Kaixian Chen; Xin Xie; Fajun Nan; Andrew A Young; Ming-Wei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-09       Impact factor: 11.205

4.  Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.

Authors:  Scott E Kanoski; Samantha M Fortin; Myrtha Arnold; Harvey J Grill; Matthew R Hayes
Journal:  Endocrinology       Date:  2011-06-21       Impact factor: 4.736

5.  Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line.

Authors:  S A Beak; M M Heath; C J Small; D G Morgan; M A Ghatei; A D Taylor; J C Buckingham; S R Bloom; D M Smith
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

6.  Interspecies modeling and prediction of human exenatide pharmacokinetics.

Authors:  Ting Chen; Donald E Mager; Leonid Kagan
Journal:  Pharm Res       Date:  2012-11-15       Impact factor: 4.200

7.  Boc5, a non-peptidic glucagon-like Peptide-1 receptor agonist, invokes sustained glycemic control and weight loss in diabetic mice.

Authors:  Haoran Su; Min He; Hongmei Li; Qing Liu; Jia Wang; Yiqian Wang; Weiwei Gao; Ling Zhou; Jiayu Liao; Andrew A Young; Ming-Wei Wang
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

8.  The endogenous preproglucagon system is not essential for gut growth homeostasis in mice.

Authors:  Pernille Wismann; Pernille Barkholt; Thomas Secher; Niels Vrang; Henrik B Hansen; Palle Bekker Jeppesen; Laurie L Baggio; Jacqueline A Koehler; Daniel J Drucker; Darleen A Sandoval; Jacob Jelsing
Journal:  Mol Metab       Date:  2017-04-27       Impact factor: 7.422

9.  Astrocytes Regulate GLP-1 Receptor-Mediated Effects on Energy Balance.

Authors:  David J Reiner; Elizabeth G Mietlicki-Baase; Lauren E McGrath; Derek J Zimmer; Kendra K Bence; Gregory L Sousa; Vaibhav R Konanur; Joanna Krawczyk; David H Burk; Scott E Kanoski; Gerlinda E Hermann; Richard C Rogers; Matthew R Hayes
Journal:  J Neurosci       Date:  2016-03-23       Impact factor: 6.167

10.  Exendin-4 Improves Nonalcoholic Fatty Liver Disease by Regulating Glucose Transporter 4 Expression in ob/ob Mice.

Authors:  Seok Kim; Jaehoon Jung; Hwajin Kim; Rok Won Heo; Chin-Ok Yi; Jung Eun Lee; Byeong Tak Jeon; Won-Ho Kim; Jong Ryeal Hahm; Gu Seob Roh
Journal:  Korean J Physiol Pharmacol       Date:  2014-08-13       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.